Li Gang, Chong Tie, Xiang Xiaolong, Yang Jie, Li Hongliang
Department of Urology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China.
Department of Nursing, Xi'an Beifang Chinese Medicine Skin Disease Hospital, Xi'an, Shaanxi 710002, P.R. China.
Oncol Rep. 2017 Oct;38(4):1995-2002. doi: 10.3892/or.2017.5901. Epub 2017 Aug 11.
The downregulation of microRNA-15a has been reported in several human tumors. However, its expression and functional importance in renal cell carcinoma (RCC) remain unknown. The aim of the present study was to investigate its expression, biological functions and underlying mechanisms in RCC tumorigenesis. The expression levels of miR-15a were examined by qRT-PCR in 40 RCC specimens and adjacent‑paired normal tissues. Cell Counting Kit-8 (CCK-8), colony formation, flow cytometry and Transwell assays were used to explore the potential influence of miR-15a transfection on RCC cell proliferation, the cell cycle, cell apoptosis, and cell invasion. Luciferase reporter assays were performed to confirm the potential target of miR-15a, in combination with qRT-PCR, western blotting and immunohistochemical assays. We found that miR-15a was significantly downregulated in most RCC specimens compared with adjacent normal tissues (P<0.01). Overexpression of miR-15a inhibited cellular growth, suppressed invasion and arrested cells at the G1/G0 phase, and induced cell apoptosis in RCC cells. Luciferase assays revealed that miR-15a directly targeted the binding site of the 3'-untranslated region (3'-UTR) of eIF4E, and inhibited its expression at both mRNA and protein levels. eIF4E expression was negatively associated with miR-15a expression in RCC tissues. eIF4E overexpression treatment partially abrogated the inhibitory effect of miR-15a on cell proliferation and invasion, as well as inactivated P13K/AKT/mTOR signaling in RCC cells. In conclusion, the present study indicated that miR-15a downregulation was associated with cell proliferation and invasion by directly targeting eIF4E during RCC progression. Thus, it may serve as a potential tumor suppressor and therapeutic target for the treatment of RCC.
已有报道称几种人类肿瘤中存在微小RNA-15a(miR-15a)的下调。然而,其在肾细胞癌(RCC)中的表达及功能重要性仍不清楚。本研究的目的是探讨其在RCC肿瘤发生中的表达、生物学功能及潜在机制。通过qRT-PCR检测了40例RCC标本及配对的癌旁正常组织中miR-15a的表达水平。采用细胞计数试剂盒-8(CCK-8)、集落形成、流式细胞术和Transwell实验,探讨miR-15a转染对RCC细胞增殖、细胞周期、细胞凋亡和细胞侵袭的潜在影响。进行荧光素酶报告基因实验以确认miR-15a的潜在靶点,并结合qRT-PCR、蛋白质印迹和免疫组织化学实验。我们发现,与癌旁正常组织相比,大多数RCC标本中miR-15a显著下调(P<0.01)。miR-15a的过表达抑制细胞生长、抑制侵袭并使RCC细胞停滞于G1/G0期,并诱导细胞凋亡。荧光素酶实验显示,miR-15a直接靶向真核翻译起始因子4E(eIF4E)3'-非翻译区(3'-UTR)的结合位点,并在mRNA和蛋白质水平抑制其表达。RCC组织中eIF4E的表达与miR-15a的表达呈负相关。eIF4E过表达处理部分消除了miR-15a对细胞增殖和侵袭的抑制作用,以及使RCC细胞中P13K/AKT/mTOR信号失活。总之,本研究表明,在RCC进展过程中,miR-15a的下调通过直接靶向eIF4E与细胞增殖和侵袭相关。因此,它可能作为RCC治疗的潜在肿瘤抑制因子和治疗靶点。